Table 2.
Among initially inactive candidates, characteristics associated with transition to active status, 2004–2011
| Characteristic | Adjusted Hazard Ratio (95% CI) | P-Value |
|---|---|---|
| Age (per decade) | 0.98 (0.97–0.99) | <0.001 |
| Female sex | 0.94 (0.92–0.97) | <0.001 |
| Race: | ||
| Caucasian | Reference | |
| African-American | 0.82 (0.80–0.85) | <0.001 |
| Other | 0.84 (0.82–0.87) | <0.001 |
| BMI (per kg/m2) | 0.98 (0.98–0.98) | <0.001 |
| Previous (non-kidney) transplant | 1.08 (0.98–1.19) | 0.1 |
| Diabetes | 0.91 (0.87–0.95) | <0.001 |
| Peripheral vascular disease | 0.84 (0.80–0.88) | <0.001 |
| Poor functional status | 0.92 (0.87–0.97) | 0.002 |
| HCV positive * | 0.89 (0.83–0.95) | <0.001 |
| Etiology of Renal Disease: | ||
| Glomerular | Reference | |
| Diabetes | 0.84 (0.79–0.88) | <0.001 |
| Congenital | 1.02 (0.98–1.07) | 0.3 |
| Hypertensive | 0.85 (0.82–0.88) | <0.001 |
| Interstitial | 0.81 (0.75–0.87) | <0.001 |
| Miscellaneous | 0.79 (0.76–0.83) | <0.001 |
| Type of RRT at listing: | ||
| Preemptive | Reference | |
| Hemodialysis | 0.95 (0.93–0.98) | 0.001 |
| Peritoneal Dialysis | 1.15 (1.09–1.20) | <0.001 |
| Multi-listed | 1.62 (1.57–1.68) | <0.001 |
| Listing year | 0.97 (0.96–0.97) | <0.001 |
*
Candidate indicated a willingness to accept an HCV positive organ – used as a proxy for the candidate’s HCV status.